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Abstract
Introduction: Chronic mesenteric ischemia is a condition that is classically associated with significant
atherosclerosis of the abdominal arteries, causing postprandial abdominal pain out of proportion to physical
examination. The abdominal pain is exacerbated after meals due to the shunting of blood away from the
intestines to the stomach, causing relative ischemia. More than 95% of chronic mesenteric ischemia cases are due
to atherosclerosis. We report the first known case of chronic mesenteric ischemia from fibromuscular dysplasia. To
the best of our knowledge, this is also the first known case in the literature where postprandial abdominal pain
was the presenting symptom of fibromuscular dysplasia.
Case presentation: A 44-year-old Caucasian woman with a history of hypertension and preeclampsia, who had
taken oral contraceptive pills for 15 years, presented with an intractable, colicky abdominal pain of two weeks
duration. This abdominal pain worsened with oral intake. It was also associated with diarrhea and vomiting.
Physical examination revealed stage III hypertension out of proportion to her risk factors and diffuse abdominal
pain without peritoneal signs. An abdominal computed tomography scan, completed in the emergency room,
revealed nonspecific colitis. Laboratory work revealed leukocytosis with a left shift, an erythrocyte sedimentation
rate of 79 and a C-reactive protein level of 100. She was started on intravenous flagyl and intravenous
ciprofloxacin. However, all microbial cultures were negative including three cultures for clostridium difficile.
Urine analysis revealed nephritic range proteinuria. The laboratory profile was within normal limits for
perinuclear-anti-neutrophil cytoplasmic antibody, cytoplasmic-anti-neutrophil cytoplasmic antibody, anti-
saccharomyces cerevisiae antibody, antinuclear antibody test, celiac profile, lactate, carbohydrate antigen-125
and thyroid stimulating hormone. A colonoscopy was completed, which revealed diffuse colonic lymphoid
reactive hyperplasia. A small bowel series was negative for any inflammation. An indium scan, pan-computed
tomography scan and transvaginal ultrasound were also negative. Magnetic resonance angiography of her
abdomen revealed proximal superior mesenteric artery stenosis, which was confirmed by computed
tomography angiogram findings of severe proximal and distal superior mesenteric artery stenosis, consistent
with the appearance of fibromuscular dysplasia on angiography in the absence of vasculitis or atherosclerotic
disease. The patient’s superior mesenteric artery stenosis was subsequently angioplastied suboptimally and had
to be stented with an Angioplus stent. One month after she was admitted, her abdominal pain and tolerance
to oral feeds improved tremendously.
Conclusion: Fibromuscular dysplasia most commonly presents with renal artery stenosis, which rarely causes
abdominal pain. This case illustrates how fibromuscular dysplasia can present as a rare cause of chronic mesenteric
ischemia, similar to chronic mesenteric ischemia from atherosclerosis.
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Chronic mesenteric ischemia is a condition classically
associated with significant atherosclerosis of the abdom-
inal arteries causing postprandial abdominal pain out of
proportion to physical examination [1]. The abdominal
pain is exacerbated after meals due to the shunting of
blood away from the intestines to the stomach causing
relative ischemia. More than 95% of chronic mesenteric
ischemia cases are due to atherosclerosis [1]. We report
the first known case of chronic mesenteric ischemia
from fibromuscular dysplasia. This is the first known
case in the literature where the presenting symptom of
fibromuscular dysplasia was postprandial abdominal
pain.
Case presentation
A 44-year-old Caucasian woman with a history of
hypertension and preeclampsia who had taken oral con-
traceptive pills (OCPs) for 15 years, presented with
intractable, colicky abdominal pain of two weeks dura-
tion. This abdominal pain worsened with oral intake. It
was also associated with diarrhea and vomiting. The
diarrhea was watery at times and was confirmed to be
hemoccult positive. Her vomiting was non-bilious and
was consistent with gastric contents, with a negative
gastroccult test. No abnormal findings were found on
physical examination except for stage III hypertension
out of proportion to her risk factors and diffuse abdom-
inal pain, which was the most prominent in the perium-
bilical area.
Routine laboratory work revealed leukocytosis (white
blood count = 16.1) with a left shift (91% polymorpho-
nuclear neutrophils), an erythrocyte sedimentation rate
(ESR) of 79, and a C-reactive protein level (CRP) of 100.
An abdominal computed tomography (CT) scan com-
pleted in the emergency room revealed nonspecific coli-
tis. It was thought that she had infectious colitis and so
she was started on intravenous (IV) flagyl and IV cipro-
floxacin. However, all microbial cultures were negative,
including three cultures for clostridium difficile. A uri-
nalysis (UA) revealed nephritic range proteinuria. At
this point, there was a concern for vasculitis, hypothyr-
oidism, and inflammatory bowel disease (IBD). The
laboratory profile was negative for perinuclear anti-neu-
trophil cytoplasmic antibodies (P-ANCA), cytoplasmic
anti-neutrophil cytoplasmic antibodies (C-ANCA), anti-
saccharomyces antibody (ASCA), antinuclear antibody
(ANA), celiac profile, lactate, carbohydrate antigen 125
(CA-125), and a thyroid stimulating hormone (TSH). A
colonoscopy was completed in order to rule out micro-
scopic colitis and occult inflammatory bowel disease
(IBD), but revealed a nonspecific finding of diffuse colo-
nic lymphoid reactive hyperplasia. A small bowel series
was negative for any inflammation and the possibility of
IBD was negated. An indium scan, looking for occult
infection, was also negative. A pan-CT scan with con-
trast looking for malignancy of the abdomen, pelvis,
chest and head were all negative. A transvaginal ultra-
sound and pelvic examination ruled out an occult early
ovarian cancer, endometrial or cervical cancer.
Although the patient was never hypotensive, nor had
any hypercoagulable conditions in the past, the diagnosis
of mesenteric ischemia was pursued based on her expo-
sure to OCP. Her OCPs had been discontinued at the
beginning of her hospitalization, which was more than a
month prior to this point in the workup. A magnetic
resonance angiography (MRA) of the abdomen revealed
proximal superior mesenteric artery (SMA) stenosis
which was confirmed by CT angiogram findings of
severe proximal and distal SMA stenosis (Figures 1 and
2). The patient was taken to angiography which revealed
near complete full length occlusion of the SMA and sev-
eral branches including mild renal artery stenosis (Fig-
ure 3). The angiography findings were consistent with
atypical fibromuscular dysplasia with a medial pattern.
The suspicion was high given the lack of atherosclerotic
lesions, absence of hyperlipidemia, negative vasculitis
workup, and pattern of occlusions seen on angiography.
The patient’s severe SMA stenosis subsequently under-
went suboptimal angioplasty, which warranted a 6 × 15
Palmaz Blue Angioplus stent (Figures 4, 5, 6). Her
symptoms improved tremendously, in that her abdom-
inal pain subsided and she had an improved tolerance
to oral feeds.
Discussion
Due to the findings of severe proximal or distal SMA
stenosis, the diagnosis of subacute mesenteric ischemia
versus chronic mesenteric ischemia was considered.
Non-occlusive mesenteric ischemia was ruled out based
on the lack of hypotension and the patient’s overall clin-
ical history. Colonic ischemia, which is the most com-
mon form of ischemic vascular compromise, was ruled
out based on the colonic biopsy and clinical history [2].
This prompted the differential diagnoses of fibromuscu-
lar dysplasia versus a hypercoagulable state causing
mesenteric vascular thrombosis, or a chronic athero-
sclerotic process with an acute thrombosis. The patient
did not have any risk factors for arterial embolic disease,
such as atrial fibrillation, valvular or heart surgery or
cardiac mural thrombosis.
The patient’s age and risk factors made the diagnosis
of chronic mesenteric ischemia from atherosclerosis
very unlikely. She had no known history of peripheral
vascular disease or an equivalent, which are high risk
factors for atherosclerosis [1]. Her body mass index was
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hospitalization. Additionally, the patient did not have a
history of hyperlipidemia or smoking, known risk factors
for atherosclerotic mesenteric ischemia. Also, most
patients with chronic mesenteric ischemia from athero-
sclerosis are over the age of 60 [1]. Thus, atherosclerotic
c h r o n i cm e s e n t e r i ci s c h e m i aw a st h o u g h tt ob eh i g h l y
unlikely.
The consideration for venous thrombosis was then
evaluated. The patient was anticoagulated with IV
heparin, which could not be continued secondary to
bleeding. The hypercoagulable workup done in the
absence of anticoagulation, including antithrombin-3
antigen level, lupus anticoagulant, beta II glycoprotein
antibody, cardiolipin antibody, protein C/S and homo-
cystinuria, showed negative results. We ruled out venous
thrombosis from antithrombin-3 deficiency and all other
hypercoagulable states. Additionally, isolated abdominal
vein thrombosis in the absence of deep venous throm-
bosis, pulmonary embolus and stroke made a hypercoa-
gulable venous state very unlikely. It was agreed by
vascular surgery from the MRA and CT angiography
findings that the patient did indeed have fibromuscular
dysplasia causing superior mesenteric artery stenosis as
well as renal artery stenosis, especially considering the
absence of hyperlipidemia and inflammation (Figures 1
and 2). The patient was taken to angiography where she
underwent a suboptimal angioplasty of her SMA, which
Figure 1 Axial image showing superior mesenteric artery (SMA) stenosis.
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Angioplus stent (Figure 3, figure 4, figure 5 and figure
6). Heparin was restarted after completing the hypercoa-
gulable work up and the patient’s clinical status
improved with anticoagulation and clopidogrel bisulfate
(Plavix). After more than a month of hospitalization, she
was discharged with clopidogrel bisulfate alone for her
abdominal stent. She was tolerating oral feeds and is
back to her baseline lifestyle at a one-year follow-up.
Several times during her care, she was advised to have
significant abdominal surgery. However, due to the
recognition of her diagnosis, our team felt confident
with her management and advised a conservative
approach. Overall, she did very well and returned to a
normal lifestyle, while avoiding significant abdominal
surgery.
Chronic mesenteric ischemia from atherosclerosis is
ideally managed with surgical correction via transaortic
endarterectomy, external iliac retrograde bypass or ante-
rograde bypass [3-9]. However, there are studies that
state stenting has been equivalent with respect to short-
term and long-term outcomes [8,9]. In our case, distal
small vessel disease of the SMA made surgery less favor-
able [10,11]. Warfarin and nitrates are typically used in
t h et r e a t m e n to fc h r o n i cm e s e n t e r i ci s c h e m i af r o m
atherosclerosis [4]. Our patient was managed with an
Figure 2 Sagittal image showing superior mesenteric artery (SMA) stenosis.
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vent stent thrombosis.
Fibromuscular dysplasia is a nonatherosclerotic, non-
inflammatory condition that leads to the narrowing of
medium sized arteries. Fibromuscular dysplasia classically
affects the renal arteries (63% to 89%) and presents most
commonly with secondary hypertension [12]. The least
common sites of involvement are the mesenteric (9%)
and iliac (5%) arteries. Fibromuscular dysplasia in atypical
sites such as the mesenteric arteries may go undiagnosed
Figure 3 Angiogram showing superior mesenteric artery (SMA) stenosis.
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classic diagnosis of fibromuscular dysplasia is made on
angiography as a ‘string of beads appearance’. However,
this only represents 60% to 70% of fibromuscular dyspla-
sia cases [12]. Atypical fibromuscular dysplasia, defined
as not representing the classic appearance, is a much
more difficult diagnosis [13,14]. Atypical fibromuscular
dysplasia is usually diagnosed on the basis of strong
clinical suspicion without signs of atherosclerotic dis-
ease or vasculitis induced inflammation, such as in our
Figure 4 Angiogram showing superior mesenteric artery (SMA) stenosis post angioplasty.
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involved arteries can mislead physicians, as it will raise
inflammatory markers. In atypical fibromuscular dyspla-
sia, the angiographic appearance can appear very similar
to atherosclerotic lesions as there are smooth concentric
lesions [12]. However, subtle distinctions can be made
as atherosclerosis is a diffuse process and does not
occur in the absence of other systemic arterial involve-
ment. Atypical fibromuscular dysplasia is much more
likely in the appropriate clinical context, such as in our
patient.
Conclusion
Fibromuscular dysplasia most commonly presents with
renal artery stenosis, which rarely causes abdominal
pain. This case illustrates how fibromuscular dysplasia
can present with postprandial abdominal pain and as a
rare cause of chronic mesenteric ischemia, similar to
chronic mesenteric ischemia from atherosclerosis. Addi-
tionally, this case also illustrates the clinical and angio-
graphic presentation of atypical fibromuscular dysplasia,
which does not present with the classic ‘string of beads’
appearance on angiography. The management of
Figure 5 Sagittal image showing superior mesenteric artery (SMA) stent.
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ischemia is similar to the management of atherosclerotic
chronic mesenteric ischemia based on this case. How-
ever, surgical revascularization is not absolutely neces-
sary in fibromuscular dysplasia induced chronic
mesenteric ischemia and abdominal artery stents with
angioplasty can be placed with successful patient out-
comes. Lastly, this case illustrates that angioplasty and
A n g i o p l u ss t e n t sc a nb eu s e dwith clopidogrel bisulfate
without warfarin or vasodilators, such as nitrates, in
chronic mesenteric ischemia secondary to fibromuscular
dysplasia.
Consent
Written consent was obtained from the patient for pub-
lication of the case report and accompanying images. A
copy of the written consent is available for review by
the Editor-in-Chief of the journal.
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